How has been the historical performance of Guj. Inject(Ker)?

Answer:The historical performance of Guj. Inject(Ker) shows significant growth in net sales, with figures rising from 0.02 crore in March 2022 to 19.05 crore in March 2025. The total operating income followed a similar trend, increasing from 0.02 crore in March 2022 to 19.05 crore in March 2025. The company has reported a consistent increase in operating profit, reaching 1.26 crore in March 2025, compared to a loss of 1.56 crore in March 2017. Profit before tax also improved significantly, from a loss of 0.01 crore in March 2019 to a profit of 1.25 crore in March 2025. The profit after tax mirrored this upward trend, rising from 0.00 crore in March 2022 to 1.02 crore in March 2025. Earnings per share (EPS) also saw a notable increase, from 0.01 in March 2017 to 0.7 in March 2025. The operating profit margin improved to 5.67% in March 2025, while the profit after tax margin reached 5.35%.

Breakdown:
Guj. Inject(Ker) has demonstrated remarkable growth over the years, particularly in net sales, which surged from negligible amounts in previous years to 19.05 crore in March 2025. This growth in sales has translated into a total operating income of 19.05 crore for the same period, marking a significant increase from just 0.02 crore in March 2022. The company has successfully turned around its operating profit, achieving 1.26 crore in March 2025, a stark contrast to the losses recorded in earlier years. Profit before tax and profit after tax have both shown substantial improvement, with the latter reaching 1.02 crore in March 2025, indicating a solid profitability trend. The earnings per share have also increased significantly, reflecting the company's enhanced financial performance. Overall, Guj. Inject(Ker) has transitioned from a phase of minimal revenue and losses to a position of profitability and growth, as evidenced by its improving margins and net profits.